Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Mallinckrodt
Daiichi Sankyo
Johnson and Johnson
Cantor Fitzgerald
Chubb
Merck
AstraZeneca
Cerilliant
Healthtrust

Generated: August 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076740

« Back to Dashboard
NDA 076740 describes NIMODIPINE, which is a drug marketed by Thepharmanetwork Llc, Heritage Pharms Inc, Sofgen Pharms, Bionpharma Inc, and Sun Pharm Inds Inc, and is included in five NDAs. It is available from nine suppliers. Additional details are available on the NIMODIPINE profile page.

The generic ingredient in NIMODIPINE is nimodipine. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nimodipine profile page.

Summary for NDA: 076740

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 076740

Ingredient-typeDihydropyridines
Mechanism of ActionCalcium Channel Antagonists

Suppliers and Packaging for NDA: 076740

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NIMODIPINE
nimodipine
CAPSULE;ORAL 076740 ANDA Heritage 23155-108 23155-108-00 10 BLISTER PACK in 1 CARTON (23155-108-00) > 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (23155-108-11)
NIMODIPINE
nimodipine
CAPSULE;ORAL 076740 ANDA Heritage 23155-108 23155-108-30 3 BLISTER PACK in 1 CARTON (23155-108-30) > 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (23155-108-11)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength30MG
Approval Date:Jan 17, 2008TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Fuji
Citi
Baxter
Mallinckrodt
AstraZeneca
Queensland Health
Daiichi Sankyo
Covington
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot